🧪 Hypotheses

mechanistic 0.88

Transcriptional Autophagy-Lysosome Coupling

🧬 FOXO1 🏥 neurodegeneration 📖 52🏛 2

✅ 0.75 ✨ 0.80 💥 0.78

## Mechanistic Overview...

mechanistic 0.82

Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD

🧬 AIM2, CASP1, IL1B, PYCARD, TARDBP 🏥 neurodegeneration 📖 31🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

mechanistic 0.80

Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration

🧬 AIM2, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 31🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

mechanistic 0.79

Targeting SASP-Complement Amplification Through HIF-1α Downstream Effectors

🧬 C1QA, C1QB, C3, IL1B 🏥 neurodegeneration 📖 10🏛 1

✅ 0.78 ✨ 0.65 💥 0.75

## Mechanistic Overview...

mechanistic 0.78

SASP-Driven Aquaporin-4 Dysregulation

🧬 AQP4 🏥 neurodegeneration 📖 34🏛 2

✅ 0.60 ✨ 0.65 💥 0.72

## Mechanistic Overview...

mechanistic 0.78

TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis

🧬 TFEB, MTOR 🏥 neurodegeneration 📖 21🏛 1

✅ 0.65 ✨ 0.70 💥 0.68

## Mechanistic Overview...

mechanistic 0.76

Cell-Type Specific TREM2 Upregulation in DAM Microglia

🧬 TREM2 🏥 Alzheimer's Disease 📖 30🏛 3

✅ 0.70 ✨ 0.65 💥 0.75

## Mechanistic Overview...

mechanistic 0.75

ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylat

🧬 ubiquitylation-dependent turnover 🏥 neurodegeneration 📖 6🏛 2

✅ 0.68 ✨ 0.76 💥 0.82

The gap can be tested by treating ubiquitylation-dependent turnover as an upstream driver rather than a passive correlate. If true, perturbing E3 liga...

mechanistic 0.75

Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Overexpression

🧬 NAMPT 🏥 neurodegeneration 📖 43🏛 3

✅ 0.84 ✨ 0.68 💥 0.77

**Molecular Mechanism and Rationale**...

mechanistic 0.74

Senescent Cell Mitochondrial DNA Release

🧬 CGAS/STING1/DNASE2 🏥 neurodegeneration 📖 37🏛 2

✅ 0.45 ✨ 0.85 💥 0.60

## Mechanistic Overview...

mechanistic 0.74

K48/K63 ubiquitin chain balance separates causal from compensatory states in: How do ALS-linked UBQLN2 mutations affect

🧬 K48/K63 ubiquitin chain balance 🏥 neurodegeneration 📖 6🏛 2

✅ 0.78 ✨ 0.72 💥 0.76

A longitudinal biomarker panel centered on K48/K63 ubiquitin chain balance can distinguish harmful mechanisms from protective adaptation. The decisive...

mechanistic 0.73

Phase-Separated Organelle Targeting

🧬 G3BP1 🏥 neurodegeneration 📖 31🏛 2

✅ 0.75 ✨ 0.70 💥 0.80

## Molecular Mechanism and Rationale...

mechanistic 0.73

TFAM overexpression creates mitochondrial donor-recipient gradients for directed organelle trafficking

🧬 TFAM 🏥 neurodegeneration 📖 38🏛 2

✅ 0.60 ✨ 0.70 💥 0.70

## Mechanistic Overview...

mechanistic 0.72

TBK1 Loss-of-Function Amplifies C1q-Mediated Synapse Elimination Through Type I IFN Hyperactivation

🧬 TBK1 🏥 neurodegeneration 📖 18🏛 1

✅ 0.45 ✨ 0.70 💥 0.60

**Molecular Mechanism and Rationale**...

mechanistic 0.72

proteasome shuttle failure defines the therapeutic window for: How do ALS-linked UBQLN2 mutations affect its ubiquitylat

🧬 proteasome shuttle failure 🏥 neurodegeneration 📖 6🏛 1

✅ 0.64 ✨ 0.79 💥 0.80

The same signal may be beneficial early and damaging late. Testing proteasome shuttle failure with autophagy flux rescue should reveal a disease-stage...

mechanistic 0.72

Circadian Rhythm Entrainment of Reactive Astrocytes

🧬 BMAL1 🏥 neurodegeneration 📖 33🏛 2

✅ 0.40 ✨ 0.75 💥 0.60

## Mechanistic Overview...

mechanistic 0.72

Stress Granule Phase Separation Modulators

🧬 G3BP1 🏥 neurodegeneration 📖 31🏛 2

✅ 0.75 ✨ 0.70 💥 0.80

## Mechanistic Overview...

mechanistic 0.71

Circadian-Synchronized LRP1 Pathway Activation

🧬 LRP1, MTNR1A, MTNR1B 🏥 neurodegeneration 📖 23🏛 2

✅ 0.60 ✨ 0.70 💥 0.50

## Mechanistic Overview...

mechanistic 0.71

Metabolic Circuit Breaker via Lipid Droplet Modulation

🧬 PLIN2 🏥 neurodegeneration 📖 35🏛 2

✅ 0.70 ✨ 0.80 💥 0.70

## Mechanistic Overview...

mechanistic 0.71

Autophagosome Maturation Checkpoint Control

🧬 STX17 🏥 neurodegeneration 📖 21🏛 2

✅ 0.45 ✨ 0.85 💥 0.75

## Molecular Mechanism and Rationale...

mechanistic 0.70

Microglial Efferocytosis Enhancement via GPR32 Superagonists

🧬 CMKLR1 🏥 neurodegeneration 📖 24🏛 2

✅ 0.60 ✨ 0.70 💥 0.70

## Mechanistic Overview...

mechanistic 0.70

Mechanosensitive Ion Channel Reprogramming

🧬 PIEZO1 and KCNK2 🏥 neurodegeneration 📖 34🏛 2

✅ 0.60 ✨ 0.80 💥 0.65

## Mechanistic Overview...

mechanistic 0.70

SARM1-Mediated NAD+ Depletion as Terminal Executor of MCT1-Dependent Axon Degeneration

🧬 SARM1, NMNAT2 🏥 neurodegeneration 📖 12🏛 1

✅ 0.55 ✨ 0.85 💥 0.72

## Mechanistic Overview...

mechanistic 0.70

Axonal RNA Transport Reconstitution

🧬 HNRNPA2B1 🏥 neurodegeneration 📖 29🏛 2

✅ 0.40 ✨ 0.85 💥 0.65

## Mechanistic Overview...

mechanistic 0.70

Mitochondrial Transfer Pathway Enhancement

🧬 MIRO1 🏥 neurodegeneration 📖 31🏛 2

✅ 0.25 ✨ 0.85 💥 0.65

## Mechanistic Overview...

mechanistic 0.69

Sphingomyelin Synthase Activators for Raft Remodeling

🧬 SGMS1/SGMS2 🏥 neurodegeneration 📖 23🏛 1

✅ 0.45 ✨ 0.85 💥 0.75

## Mechanistic Overview...

mechanistic 0.69

Cross-Seeding Prevention Strategy

🧬 TARDBP 🏥 neurodegeneration 📖 22🏛 2

✅ 0.64 ✨ 0.55 💥 0.71

## Mechanistic Overview...

mechanistic 0.69

CX43 hemichannel engineering enables size-selective mitochondrial transfer

🧬 GJA1 🏥 neurodegeneration 📖 30🏛 2

✅ 0.40 ✨ 0.70 💥 0.60

## Mechanistic Overview...

mechanistic 0.69

TREM2 Conformational Stabilizers for Synaptic Discrimination

🧬 TREM2 🏥 neurodegeneration 📖 30🏛 2

✅ 0.25 ✨ 0.90 💥 0.70

## Mechanistic Overview...

mechanistic 0.67

RAB27A-dependent extracellular vesicle engineering for mitochondrial cargo delivery

🧬 RAB27A 🏥 neurodegeneration 📖 21🏛 2

✅ 0.45 ✨ 0.85 💥 0.60

## Mechanistic Overview...